Literature DB >> 21161411

Content validation of two SF-36 subscales for use in type 2 diabetes and non-dialysis chronic kidney disease-related anemia.

Mona L Martin1, Donald L Patrick, Shravanthi R Gandra, Antonia V Bennett, Nancy K Leidy, Allen R Nissenson, Fredric O Finkelstein, Eldrin F Lewis, Albert W Wu, John E Ware.   

Abstract

PURPOSE: This study aimed to evaluate the relevance and importance of two SF-36 subscales, Vitality (VT) and Physical Function (PF), to assess concepts of energy and physical function in patients with type 2 diabetes mellitus (DM) and non-dialysis CKD-related anemia.
METHODS: Patients with clinical history of DM and non-dialysis CKD-related anemia (n = 68) were identified as follows: 40 participated in concept elicitation (CE) interviews; 20 in cognitive interviews (CI), and 8 in pilot interviews. Relevance and importance ratings for SF-36 VT and PF items were obtained. Interviews were recorded, transcribed, and patient expressions of concepts coded. Inter-rater agreement was used to evaluate coding consistency. Concepts elicited were mapped to SF-36 VT and PF items.
RESULTS: Patients (n = 64) were 65.6% women, 42.2% Caucasian, with mean age of 66.1 ± 11.6 years. Of 830 coded concepts, 388 (47%) were "Energy" expressions and 287 (35%) were "PF limitations" expressions. Low energy was reported by 85% patients and rated as an important limitation by 88%. Limitations in PF were reported by 56-82% patients and rated important by 44-96%. CE and CI quotes correspond well to SF-36 VT and PF items.
CONCLUSION: SF-36 VT and PF contents were suitable for assessing energy and physical function limitations, respectively, in this patient population.

Entities:  

Mesh:

Year:  2010        PMID: 21161411     DOI: 10.1007/s11136-010-9812-4

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  12 in total

1.  Epidemiology of anemia associated with chronic renal insufficiency among adults in the United States: results from the Third National Health and Nutrition Examination Survey.

Authors:  Chi-Yuan Hsu; Charles E McCulloch; Gary C Curhan
Journal:  J Am Soc Nephrol       Date:  2002-02       Impact factor: 10.121

Review 2.  Health related quality of life in patients with chronic kidney disease.

Authors:  Kamyar Kalantar-Zadeh; Mark Unruh
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

Review 3.  Patient-reported outcomes to support medical product labeling claims: FDA perspective.

Authors:  Donald L Patrick; Laurie B Burke; John H Powers; Jane A Scott; Edwin P Rock; Sahar Dawisha; Robert O'Neill; Dianne L Kennedy
Journal:  Value Health       Date:  2007 Nov-Dec       Impact factor: 5.725

4.  A survey method for characterizing daily life experience: the day reconstruction method.

Authors:  Daniel Kahneman; Alan B Krueger; David A Schkade; Norbert Schwarz; Arthur A Stone
Journal:  Science       Date:  2004-12-03       Impact factor: 47.728

5.  Prevalence of chronic kidney disease in the United States.

Authors:  Josef Coresh; Elizabeth Selvin; Lesley A Stevens; Jane Manzi; John W Kusek; Paul Eggers; Frederick Van Lente; Andrew S Levey
Journal:  JAMA       Date:  2007-11-07       Impact factor: 56.272

6.  The prevalence of anemia in patients with chronic kidney disease.

Authors:  William McClellan; Stephen L Aronoff; W Kline Bolton; Sally Hood; Daniel L Lorber; K Linda Tang; Thomas F Tse; Brian Wasserman; Marc Leiserowitz
Journal:  Curr Med Res Opin       Date:  2004-09       Impact factor: 2.580

7.  Patients' priorities for health research: focus group study of patients with chronic kidney disease.

Authors:  Allison Tong; Peter Sainsbury; Stacy M Carter; Bronwyn Hall; David C Harris; Rowan G Walker; Carmel M Hawley; Steven Chadban; Jonathan C Craig
Journal:  Nephrol Dial Transplant       Date:  2008-04-29       Impact factor: 5.992

8.  Patients' experiences and perspectives of living with CKD.

Authors:  Allison Tong; Peter Sainsbury; Steven Chadban; Rowan G Walker; David C Harris; Stacy M Carter; Bronwyn Hall; Carmel Hawley; Jonathan C Craig
Journal:  Am J Kidney Dis       Date:  2009-02-11       Impact factor: 8.860

Review 9.  The impact of selecting a high hemoglobin target level on health-related quality of life for patients with chronic kidney disease: a systematic review and meta-analysis.

Authors:  Fiona M Clement; Scott Klarenbach; Marcello Tonelli; Jeffrey A Johnson; Braden J Manns
Journal:  Arch Intern Med       Date:  2009-06-22

Review 10.  Impact of erythropoiesis-stimulating agents on energy and physical function in nondialysis CKD patients with anemia: a systematic review.

Authors:  Shravanthi R Gandra; Fredric O Finkelstein; Antonia V Bennett; Eldrin F Lewis; Tracy Brazg; Mona L Martin
Journal:  Am J Kidney Dis       Date:  2009-12-23       Impact factor: 8.860

View more
  8 in total

1.  Experiences of gout-related disability from the patients' perspective: a mixed methods study.

Authors:  Peter M ten Klooster; Harald E Vonkeman; Martijn A H Oude Voshaar; Christina Bode; Mart A F J van de Laar
Journal:  Clin Rheumatol       Date:  2014-08       Impact factor: 2.980

2.  Evaluation of smoking-specific and generic quality of life measures in current and former smokers in Germany and the United States.

Authors:  John E Ware; Barbara Gandek; Anuradha Kulasekaran; Rick Guyer
Journal:  Health Qual Life Outcomes       Date:  2015-08-16       Impact factor: 3.186

3.  Measurement properties of the Short Form-36 (SF-36) and the Functional Assessment of Cancer Therapy - Anemia (FACT-An) in patients with anemia associated with chronic kidney disease.

Authors:  Fredric O Finkelstein; Floortje van Nooten; Ingela Wiklund; Dylan Trundell; David Cella
Journal:  Health Qual Life Outcomes       Date:  2018-05-31       Impact factor: 3.186

Review 4.  Patient-reported outcome measures for assessing health-related quality of life in people with type 2 diabetes: A systematic review.

Authors:  Marlous Langendoen-Gort; Lenka Groeneveld; Cecilia A C Prinsen; Joline W Beulens; Petra J M Elders; Ilana Halperin; Geetha Mukerji; Caroline B Terwee; Femke Rutters
Journal:  Rev Endocr Metab Disord       Date:  2022-07-02       Impact factor: 9.306

5.  Health-related quality of life and all-cause mortality in patients with diabetes on dialysis.

Authors:  Tone Britt Hortemo Osthus; Nanna von der Lippe; Lis Ribu; Tone Rustøen; Torbjørn Leivestad; Toril Dammen; Ingrid Os
Journal:  BMC Nephrol       Date:  2012-08-03       Impact factor: 2.388

6.  Standardizing disease-specific quality of life measures across multiple chronic conditions: development and initial evaluation of the QOL Disease Impact Scale (QDIS®).

Authors:  John E Ware; Barbara Gandek; Rick Guyer; Nina Deng
Journal:  Health Qual Life Outcomes       Date:  2016-06-02       Impact factor: 3.186

7.  Clinical, Functional, and Biological Correlates of Cognitive Dimensions in Major Depressive Disorder - Rationale, Design, and Characteristics of the Cognitive Function and Mood Study (CoFaM-Study).

Authors:  Bernhard T Baune; Tracy Air
Journal:  Front Psychiatry       Date:  2016-08-26       Impact factor: 4.157

Review 8.  Patient-Reported Outcomes in Patients with Chronic Kidney Disease and Kidney Transplant-Part 1.

Authors:  Evan Tang; Aarushi Bansal; Marta Novak; Istvan Mucsi
Journal:  Front Med (Lausanne)       Date:  2018-01-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.